An in-silico study of the type II NADH: Quinone Oxidoreductase (ndh2). A new anti-malaria drug target

dc.contributor.advisorLobb, Kevin
dc.contributor.advisorMoses, Vuyani
dc.contributor.authorBaye, Bertha Cinthia
dc.date.accessioned2026-03-03T13:10:25Z
dc.date.issued14/10/2022
dc.description.abstractMalaria is caused by Plasmodium parasites, spread to people through the bites of infected female Anopheles mosquitoes. This study focuses on all 5 (Plasmodium falciparum, Plasmodium knowlesi, Plasmodium malariae, Plasmodium ovale and Plasmodium vivax) parasites that cause malaria in humans. Africa is a developing continent, and it is the most affected with an estimation of 90% of more than 400 000 malaria-related deaths reported by the World Health Organization (WHO) report in 2020, in which 61% of that number are children under the ages of five. Malaria resistance was initially observed in early 1986 and with the progression of time anti-malarial drug resistance has only increased. As a result, there is a need to study the malarial proteins mechanism of action and identify alternative treatment strategies for this disease. Type II NADH: quinone oxidoreductase (NDH2) is a monotopic protein that catalyses the electron transfer from NADH to quinone via FAD without a proton-pumping activity, and functions as an initial enzyme, either in addition to or as an alternative to proton-pumping NADH dehydrogenase (complex I) in the respiratory chain of bacteria, archaea, and fungal and plant mitochondrial. The structures for the Plasmodium knowlesi, Plasmodium malariae, Plasmodium ovale and Plasmodium vivax were modelled from the crystal structure of Plasmodium falciparum (5JWA). Compounds from the South African natural compounds database (SANCDB) were docked against both the NDH2 crystal structure and modelled structures. By performing in silico screening the study aimed to find potential compounds that might interrupt the electron transfer to quinone therefore disturbing the enzyme"Ÿs function and thereby possibly eliminating the plasmodium parasite. CHARMM-GUI was used to create the membrane (since this work is with membrane-bound proteins) and to orient the protein on the membrane using OPM server guidelines, the interface produced GROMACS topology files that were used in molecular dynamics simulations. Molecular dynamics simulations were performed in the Centre for high performance computing (CHPC) cluster under the CHEM0802 project and the trajectories produced were further analysed. In this work not only were hit compounds from SANCDB identified, but also differences in behaviour across species and in the presence or absence of the membrane were described. This highlights the need to include the correct protein environment when studying these systems.
dc.description.degreeDoctoral theses
dc.description.degreePhD
dc.format.extent171 pages
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.21504/10962/365633
dc.identifier.otherhttp://hdl.handle.net/10962/365633
dc.identifier.urihttps://researchrepository.ru.ac.za/handle/123456789/4008
dc.languageEnglish
dc.publisherRhodes University, Faculty of Science, Department of Biochemistry and Microbiology
dc.rightsBaye, Bertha Cinthia
dc.subjectMalaria
dc.subjectPlasmodium
dc.subjectMolecular dynamics
dc.subjectComputer simulation
dc.subjectQuinone
dc.subjectAntimalarials
dc.subjectMolecules Models
dc.subjectDocking
dc.subjectDrugs Computer-aided design
dc.titleAn in-silico study of the type II NADH: Quinone Oxidoreductase (ndh2). A new anti-malaria drug target
dc.typeAcademic thesis

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
An_in-silico_study_of_the_type_II_NADH__Quinone_Ox_vital_65767.pdf
Size:
5.82 MB
Format:
Adobe Portable Document Format